Improved efficiency in detecting cellular immunity towards M. tuberculosis in patients receiving immunosuppressive drug therapy

Nephrol Dial Transplant. 2006 Nov;21(11):3258-68. doi: 10.1093/ndt/gfl416. Epub 2006 Aug 25.

Abstract

Background: Reactivation of a latent Mycobacterium tuberculosis infection in immunocompromised individuals is associated with significant morbidity and mortality. The limited sensitivity of the established tuberculin skin-test in identifying latently infected patients on immunosuppressive drug therapy represents a major obstacle to better tuberculosis control after transplantation.

Methods: In this study, a quantitative flow-cytometric whole-blood assay and the skin-test were comparatively evaluated towards both diagnostic power and practicability in 117 long-term renal transplant recipients (age 53.1+/-14.8 years; 7.0+/-5.0 years after transplantation) in a low-prevalence region.

Results: Among the aforementioned renal transplant recipients, a high proportion (52.14%) had purified protein-derivative (PPD)-specific T-cell-immunity in vitro. Despite immunosuppression, prevalence as well as median frequencies of PPD-specific T-cells (0.22%; >0.05-4.71%) were as high as previously reported for immunocompetent individuals and haemodialysis patients. In contrast to in vitro testing, skin testing was less practicable in an ambulatory setting. Moreover, skin-test reactivity was significantly reduced as only 50.0% of patients with PPD-reactivity in vitro were skin-test positive. T-cell reactivity towards early secretory antigenic target-6 (ESAT-6), a protein specific for M. tuberculosis but absent from the bacillus Calmette-Guerin BCG-vaccine strain, was found in 52.9% of all individuals with PPD-reactivity in vitro.

Conclusions: In conclusion, the whole-blood assay reveals a high prevalence of latent tuberculosis infection in renal transplant recipients. It may represent a valuable alternative to skin testing as the test result is not adversely affected by immunosuppression. Moreover, reactivity towards ESAT-6 allows the distinction of a latent infection from BCG-induced reactivity. The assay is well-suited for use in screening programmes and may facilitate the management of tuberculosis infection in immunocompromised individuals.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • CD4 Lymphocyte Count
  • Cohort Studies
  • Enzyme-Linked Immunosorbent Assay
  • Graft Rejection / microbiology
  • Graft Rejection / prevention & control
  • Humans
  • Immunity, Cellular
  • Immunosuppressive Agents / therapeutic use*
  • Kidney Diseases / drug therapy*
  • Kidney Diseases / immunology
  • Kidney Diseases / microbiology
  • Kidney Transplantation*
  • Middle Aged
  • Mycobacterium tuberculosis / immunology*
  • Predictive Value of Tests
  • Sensitivity and Specificity
  • Skin Tests
  • Tuberculin / immunology
  • Tuberculosis / diagnosis*
  • Tuberculosis / immunology*

Substances

  • Immunosuppressive Agents
  • Tuberculin